Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: squetch who wrote (5009)	5/29/1998 3:38:00 PM
From: Rocketman	Read Replies (3) \| Respond to of 9719

Friday May 29, 2:54 pm Eastern Time RESEARCH ALERT - Incyte restarted NEW YORK, May 29 (Reuters) - SBC Warburg Dillon Read said on Friday it restarted coverage on shares of Incyte Pharmaceuticals with a buy rating. -- Company has established itself as dominant player in the fast growing genomics industry, analyst A. Rachel Leheny said. -- Company has built a proprietary database that contains the majority of human genes as well as a group of related databases including a full-length clone database. -- Stock has recently been under pressure due to perceptions of competition in its midst but analyst said believes competition has been overstated. biz.yahoo.com >>>>>>>>>>> They are starting to catch on!!! Rman